✦ LIBER ✦

An evaluation of serum osteocalcin in pacet's disease of bone and its response to diphosphonate treatment

✍ Scribed by Les A. Coulton; Christopher J. Preston; Malcolm Couch; John A. Kanis

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 520 KB
Volume: 31
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780310909

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical and clinical responses to di

Biochemical and clinical responses to dichloromethylene diphosphonate (cl2mdp) in paget's disease of bone

✍ D. L. Douglas; T. Duckworth; J. A. Kanis; C. Preston; D. J. Beard; T. W. D. Smit 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Serum osteoprotegerin and its ligand in

Serum osteoprotegerin and its ligand in Paget's disease of bone: Relationship to disease activity and effect of treatment with bisphosphonates

✍ L. Alvarez; P. Peris; N. Guañabens; S. Vidal; I. Ros; F. Pons; X. Filella; A. Mo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Sequential evaluation of serum hepcidin

Sequential evaluation of serum hepcidin in anemic myeloma patients: Study of correlations with myeloma treatment, disease variables, and anemia response

✍ Eirini Katodritou; Tomas Ganz; Evangelos Terpos; Evgenia Verrou; Gordana Olbina; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 802 KB

Hepcidin is a liver-derived hormone with a central role in iron regulation and in anemia of inflammation. Its correlations with disease variables, anemia response (AR), and responses to treatment have not been investigated in multiple myeloma (MM). A cohort of anemic MM patients undergoing treatment

Discussion: Newer bisphosphonates in the

Discussion: Newer bisphosphonates in the treatment of paget's disease of bone: Where we are and where we want to go

✍ Andreas Grauer; Henry Bone; Eugene V. Mccloskey; Michael Mcclung; Donald H. Gutt 📂 Article 📅 1999 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 569 KB

Virological and pharmacological factors

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097)

✍ Constance Delaugerre; Gilles Peytavin; Stephanie Dominguez; Anne-Genevieve Marce 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract Both highly potent antiretroviral drug rescue multi therapy and treatment interruption (TI) have been suggested to be effective in HIV‐1 infected‐patients with multiple treatment failure. GigHAART‐ANRS 097 was the only randomized trial during which an 8‐week TI was beneficial in heavily